WKN: | 850501 |
ISIN: | US1101221083 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Pharma |
Weshalb die Bristol-Myers-Aktie
ein C-Rating hat,
erfahren Sie im Performance-Check
vom 06. September 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 1997 | 21,31 | 42,18 | 97,94% |
2 | 2013 | 24,55 | 39,15 | 59,47% |
3 | 2011 | 19,75 | 27,48 | 39,14% |
4 | 1998 | 42,18 | 56,24 | 33,33% |
5 | 2019 | 44,21 | 57,61 | 30,31% |
6 | 2015 | 49,45 | 64,15 | 29,73% |
7 | 2014 | 39,15 | 49,45 | 26,31% |
8 | 2022 | 55,02 | 67,15 | 22,05% |
9 | 2000 | 65,00 | 77,60 | 19,38% |
10 | 2024 | 46,60 | 54,85 | 17,70% |
11 | 1999 | 56,24 | 65,00 | 15,58% |
12 | 2009 | 16,30 | 18,30 | 12,27% |
13 | 2021 | 50,34 | 55,02 | 9,30% |
14 | 2010 | 18,30 | 19,75 | 7,92% |
15 | 2005 | 18,62 | 19,80 | 6,34% |
16 | 2003 | 22,25 | 22,65 | 1,80% |
17 | 2006 | 19,80 | 19,86 | 0,30% |
18 | 2007 | 19,86 | 18,37 | -7,50% |
19 | 2017 | 55,84 | 51,34 | -8,06% |
20 | 2012 | 27,48 | 24,55 | -10,66% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2002 | 60,00 | 22,25 | -62,92% |
2 | 2023 | 67,15 | 46,60 | -30,60% |
3 | 2025 | 54,85 | 39,85 | -27,35% |
4 | 2001 | 77,60 | 60,00 | -22,68% |
5 | 2004 | 22,65 | 18,62 | -17,79% |
6 | 2018 | 51,34 | 44,21 | -13,89% |
7 | 2016 | 64,15 | 55,84 | -12,95% |
8 | 2020 | 57,61 | 50,34 | -12,62% |
9 | 2008 | 18,37 | 16,30 | -11,27% |
10 | 2012 | 27,48 | 24,55 | -10,66% |
11 | 2017 | 55,84 | 51,34 | -8,06% |
12 | 2007 | 19,86 | 18,37 | -7,50% |
13 | 2006 | 19,80 | 19,86 | 0,30% |
14 | 2003 | 22,25 | 22,65 | 1,80% |
15 | 2005 | 18,62 | 19,80 | 6,34% |
16 | 2010 | 18,30 | 19,75 | 7,92% |
17 | 2021 | 50,34 | 55,02 | 9,30% |
18 | 2009 | 16,30 | 18,30 | 12,27% |
19 | 1999 | 56,24 | 65,00 | 15,58% |
20 | 2024 | 46,60 | 54,85 | 17,70% |